Cite

HARVARD Citation

    Mallah, S. et al. (2023). Safety and efficacy of COVID-19 prime-boost vaccinations: Homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed individuals. Vaccine. 41 (12), pp. 1925-1933. [Online]. 
  
Back to record